1. Removing Barriers in the HCV Cascade of Care

2. Program Overview

3. HCV Burden of Disease

4. Worldwide HCV Prevalence (2015)

5. Global Annual Mortality

6. Disability From Liver Disease Has Increased (2006-2016)

7. Outline of HCV Long-Term Complications Natural History of Hepatitis C

8. Progression to Cirrhosis

9. Progression to Cirrhosis (cont)

10. Extrahepatic Manifestations of HCV Infection

11. Improving the HCV Cascade of Care

12. WHO Vision

13. HCV Cascade of Care (British Columbia, Canada)

14. HCV Cascade of Care (British Columbia, Canada) (cont)

15. HCV Cascade of Care (British Columbia, Canada) (cont)

16. Screening Strategies

17. ELISA Assays

18. NAT Testing (rtPCR or TMA)

19. Point-of-Care Tests

20. Rapid Diagnostic Tests (RDT)

21. Dried Blood Spots (DBS)

22. Confirmation of Replication

23. Screening Linkage to Care

24. Decentralized Screening and Care

25. Simplified Pretherapeutic Assessment

26. EASL Recommendations on the Treatment of Hepatitis C 2018

27. Treatment Monitoring

28. Simplified Treatment Monitoring

29. HCV Elimination Strategies

30. HCV Elimination Strategies

31. HCV Elimination Strategies

32. Micro-Elimination Target Groups

33. US Veterans

34. Concluding Remarks

35. Abbreviations

36. Abbreviations (cont)